Inhibikase Therapeutics Inc (IKT)
Cost of Revenue
$0.00
Quarterly · Period ending: · USD
IKT Cost of Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
IKT Quarterly Cost of Revenue ($256.89K → $0.00)
Quarterly cost of revenue
High-resolution chart · PNG
IKT cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 6,567 | |
| 6,568 | |
| 6,569 | |
| 6,568 | |
| 6,568 | |
| 6,568 | |
| 159,204 | |
| 5,043 | |
| 5,042 | |
| 1,681 | |
| 2,982,183 | |
| 3,016,991 | |
| 3,390,258 | |
| 3,154,553 | |
| 2,382,433 | |
| 2,431,860 | |
| 226,944 | |
| 120,569 | |
| 263,175 | |
| 283,114 | |
| 267,915 | |
| 254,967 | |
| 474,047 | |
| 1,555,781 | |
| 1,345,077 | |
| 585,291 | |
| 797,399 | |
| 256,890 |